Open AccessVenous thromboembolism in COVID-19: systematic review of reported risks and current guidelines
Author(s) -
Pierre Fontana,
Alessandro Casini,
Helia RobertEbadi,
Fréderic Glauser,
Marc Righini,
Marc Blondon
Publication year - 2020
Publication title -
swiss medical weekly
Language(s) - English
Resource type - Journals
eISSN - 1424-7860
pISSN - 1424-3997
DOI - 10.4414/smw.2020.20301
Subject(s) - medicine , covid-19 , intensive care medicine , venous thromboembolism , current (fluid) , systematic review , medline , betacoronavirus , coronavirus infections , virology , pathology , thrombosis , disease , outbreak , electrical engineering , engineering , law , political science , infectious disease (medical specialty)
Venous thromboembolism very commonly complicates the clinical course of inpatients with COVID-19, despite thromboprophylaxis. The risk appears highest among critically ill inpatients. We found no estimates of risks among outpatients. Many questions remain unresolved, as delineated by the heterogeneity of national and international guidelines. This situation calls for fast randomised clinical trials, comparing different schemes of thromboprophylaxis in COVID-19 inpatients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom